Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Assets Average (2020 - 2024)

RAPT Therapeutics' Assets Average history spans 5 years, with the latest figure at $117.8 million for Q3 2024.

  • For Q3 2024, Assets Average fell 43.96% year-over-year to $117.8 million; the TTM value through Sep 2024 reached $117.8 million, down 43.96%, while the annual FY2023 figure was $219.8 million, 5.44% down from the prior year.
  • Assets Average for Q3 2024 was $117.8 million at RAPT Therapeutics, down from $141.5 million in the prior quarter.
  • Across five years, Assets Average topped out at $257.3 million in Q1 2023 and bottomed at $112.4 million in Q1 2021.
  • The 5-year median for Assets Average is $189.8 million (2022), against an average of $182.3 million.
  • The largest annual shift saw Assets Average surged 71.72% in 2022 before it plummeted 43.96% in 2024.
  • A 5-year view of Assets Average shows it stood at $124.0 million in 2020, then surged by 67.82% to $208.0 million in 2021, then rose by 14.32% to $237.8 million in 2022, then decreased by 21.58% to $186.5 million in 2023, then plummeted by 36.83% to $117.8 million in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Assets Average are $117.8 million (Q3 2024), $141.5 million (Q2 2024), and $164.6 million (Q1 2024).